Protective effect of a Chinese medicine formula He-Ying-Qing-Re formula on diabetic retinopathy

Journal of Ethnopharmacology

Volumn 169, Issue , 2015, Pages 295-304

  Wang, Leilei ^a,b   Wang, Ning ^b   Tan, Hor Yue ^b   Zhang, Yinjian ^a   Feng, Yibin ^b  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Advanced glycation end products; Blood retina barrier breakdown; Diabetic retinopathy; He Ying Qing Re Formula; Retinal vasculature degeneration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ARCTIN; CHINESE DRUG; CHLOROGENIC ACID; CLAUDIN 1; FERULIC ACID; GLUCOSE; HE YING QING RE; METFORMIN; NATURAL PRODUCT; PROTEIN KINASE B; PROTEIN ZO1; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; HE-YING-QING-RE; HERBACEOUS AGENT; PLANT EXTRACT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD RETINA BARRIER; CELL MIGRATION; CHINESE MEDICINE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EYE PROTECTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TIGHT JUNCTION; WOUND HEALING; ANIMAL; BLOOD; CELL CULTURE; CELL MIGRATION ASSAY; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM; RETINAL DEGENERATION;

RODENTIA;

ANIMALS; BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; CELL MIGRATION ASSAYS; CELLS, CULTURED; CLAUDIN-1; DIABETIC RETINOPATHY; DRUGS, CHINESE HERBAL; GLUCOSE TOLERANCE TEST; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MICE; PLANT EXTRACTS; RETINAL DEGENERATION; STREPTOZOCIN;

EID: 84929322685     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2015.04.031     Document Type: Article

References (58)

1. E. Abdel-Rahman, and W.K. Bolton Pimagedine: a novel therapy for diabetic nephropathy Expert Opin. investig. drugs 11 2002 565 574
2. T. Arai, K. Morimoto, M. Oka, T. Hikita, K. Arai, K. Umezawa, M. Nagase, and T. Yamamoto Aminoguanidine induces haematuria of non-glomerular origin in spontaneously hypertensive rats Nephrol. Dial. Transplant. 15 2000 811 817
3. F. Bandello, R. Lattanzio, I. Zucchiatti, and C. Del Turco Pathophysiology and treatment of diabetic retinopathy Acta Diabetol. 50 2013 1 20
4. J. Barbosa Diabetes: the science and the art. Hyperglycemia v complications Arch. Intern. Med. 143 1983 1118 1119
5. M. Belkin, O. Kalter-Leibovici, A. Chetrit, and A. Skaat Time trends in the incidence and causes of blindness in Israel Am. J. Ophthalmol. 155 2013 404
6. P.A. Campochiaro, D.M. Brown, A. Pearson, T. Ciulla, D. Boyer, F.G. Holz, M. Tolentino, A. Gupta, L. Duarte, S. Madreperla, J. Gonder, B. Kapik, K. Billman, and F.E. Kane Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema Ophthalmology 118 2011 626 635
7. P. Canning, J.V. Glenn, D.K. Hsu, F.T. Liu, T.A. Gardiner, and A.W. Stitt Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes Exp. Diabetes Res. 2007 2007 51837
8. M. Cavey, M. Rauzi, P.F. Lenne, and T. Lecuit A two-tiered mechanism for stabilization and immobilization of E-cadherin Nature 453 2008 751 756
9. J.C. Chou, S.D. Rollins, and A.A. Fawzi Trypsin digest protocol to analyze the retinal vasculature of a mouse model J. Vis. Exp. 2013 e50489
10. Y. Cui, J. Wu, X. Li, and Y. Li Influence of SiMiaoYongAn decoction on VEC, ET and inflammatory factors of diabetic foot syndrome Henan Tradit. Chin. Med. 29 2009 151 152
11. E. Dejana, and C. Giampietro Vascular endothelial-cadherin and vascular stability Curr. Opin. Hematol. 19 2012 218 223
12. N. Dietrich, and H.P. Hammes Retinal digest preparation: a method to study diabetic retinopathy Methods Mol. Biol. 933 2012 291 302
13. A.H. El Shazly, A.M. Mahmoud, and N.S. Darwish Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals Acta Pharm. 59 2009 67 73
14. D.J. Feenstra, E.C. Yego, and S. Mohr Modes of retinal cell death in diabetic retinopathy J. Clin. Exp. Ophthalmol. 4 2013 298
15. R.A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T.S. Kern, and D.F. Chen Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes Investig. Ophthalmol. Vis. Sci. 46 2005 4281 4287
16. M.C. Gillies, F.K. Sutter, J.M. Simpson, J. Larsson, H. Ali, and M. Zhu Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial Ophthalmology 113 2006 1533 1538
17. C.Y. Gong, Z.Y. Yu, B. Lu, L. Yang, Y.C. Sheng, Y.M. Fan, L.L. Ji, and Z.T. Wang Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism Vas. Pharmacol. 62 2014 134 142
18. S.A. Kandarakis, C. Piperi, F. Topouzis, and A.G. Papavassiliou Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases Prog. Retin. Eye Res 2014
19. T.S. Kern, and R.L. Engerman Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin Diabetes 50 2001 1636 1642
20. H.Y. Kim, and K. Kim Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro J. Agric. Food Chem. 51 2003 1586 1591
21. J. Kim, C.S. Kim, E. Sohn, Y.M. Lee, K. Jo, and J.S. Kim KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo PloS one 7 2012 e43591
22. J.H. Kim, J.H. Kim, H.O. Jun, Y.S. Yu, and K.W. Kim Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy Am. J. Pathol. 176 2010 1517 1524
23. I. Klaassen, C.J. Van Noorden, and R.O. Schlingemann Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions Prog. Retin. Eye Res. 34 2013 19 48
24. B.D. Kuppermann, M.S. Blumenkranz, J.A. Haller, G.A. Williams, D.V. Weinberg, C. Chou, and S.M. Whitcup Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch. Ophthalmol. 125 2007 309 317
25. J. Lee, D.S. Jang, N.H. Kim, Y.M. Lee, J. Kim, and J.S. Kim Galloyl glucoses from the seeds of Cornus officinalis with inhibitory activity against protein glycation, aldose reductase, and cataractogenesis ex vivo Biol. Pharm. Bull. 34 2011 443 446
26. L. Li, and G. Renier Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression Metab.: Clin. Exp. 55 2006 1516 1523
27. D. Luo, Y. Fan, and X. Xu The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats Bioorg. Med. Chem. Lett. 22 2012 4386 4390
28. X.X. Luo, J.G. Duan, P.Z. Liao, L. Wu, Y.G. Yu, B. Qiu, Y.L. Wang, Y.M. Li, Z.Q. Yin, X.L. Liu, and K. Yao Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial Chin. J. Integr. Med. 15 2009 384 388
29. E. Mannucci, M. Monami, C. Lamanna, and J.E. Adalsteinsson Post-prandial glucose and diabetic complications: systematic review of observational studies Acta Diabetol. 49 2012 307 314
30. D.R. Masser, H.D. VanGuilder Starkey, G.V. Bixler, W. Dunton, S.K. Bronson, and W.M. Freeman Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats Exp. Eye Res. 125 2014 95 106
31. D.J. McKenna, J. Nelson, and A.W. Stitt Advanced glycation alters expression of the 67 kDa laminin receptor in retinal microvascular endothelial cells Life Sci. 68 2001 2695 2703
32. R. Milne, and S. Brownstein Advanced glycation end products and diabetic retinopathy Amino Acids 44 2013 1397 1407
33. G. Mohammad, M.M. Siddiquei, A. Othman, M. Al-Shabrawey, and A.M. Abu El-Asrar High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina Exp. Eye Res. 107 2013 101 109
34. V.M. Monnier, D.R. Sell, R.H. Nagaraj, S. Miyata, S. Grandhee, P. Odetti, and S.A. Ibrahim Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia Diabetes 41 Suppl 2 1992 S36 S41
35. T.C. Moore, J.E. Moore, Y. Kaji, N. Frizzell, T. Usui, V. Poulaki, I.L. Campbell, A.W. Stitt, T.A. Gardiner, D.B. Archer, and A.P. Adamis The role of advanced glycation end products in retinal microvascular leukostasis Investig. Ophthalmol. Vis. Sci. 44 2003 4457 4464
36. A. Mozayan, and S. Farah Acute anterior uveitis following intravitreal injection of bevacizumab Ophthalmic Surg. Lasers Imaging Retina 44 2013 25 27
37. B. Nie, Y. Xu, B. Xu, H. Zhu, S. Wu, L. Xie, and L. Chen Effects of Extracts of Simiao Yong'an Decoction on Expressions of Intrerceclluar Adhesion Molecular -1 and Matrix Metalloproteinase-9 in Macrophage Induced by LPS LiaoNing J. Tradit. Chin. Med. 40 2013 1479 1481
38. M.S. Ola, M.I. Nawaz, M.M. Siddiquei, S. Al-Amro, and A.M. Abu El-Asrar Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy J. Diabetes Complicat. 26 2012 56 64
39. C. Pang, L. Jia, S. Jiang, W. Liu, X. Hou, Y. Zuo, H. Gu, Y. Bao, Q. Wu, K. Xiang, X. Gao, and W. Jia Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study Diabetes/Metab. Res. Rev. 28 2012 276 283
40. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, M. Woodward, M. Marre, M. Cooper, P. Glasziou, D. Grobbee, P. Hamet, S. Harrap, S. Heller, L. Liu, G. Mancia, C.E. Mogensen, C. Pan, N. Poulter, A. Rodgers, B. Williams, S. Bompoint, B.E. de Galan, R. Joshi, and F. Travert Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N. Engl. J. Med. 358 2008 2560 2572
41. L. Peng, M. Li, Y. Xu, G. Zhang, C. Yang, Y. Zhou, L. Li, and J. Zhang Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model J. Ethnopharmacol. 143 2012 241 248
42. R. Ramasamy, S.J. Vannucci, S.S. Yan, K. Herold, S.F. Yan, and A.M. Schmidt Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation Glycobiology 15 2005 16r 28r
43. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Investig. 108 2001 949 955
44. Howard Schatz, D. Maderia, and H. Richard McDonald Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema Acta Ophthalmol. 109 1991 1549 1551
45. H. Shikari, P.S. Silva, and J.K. Sun Complications of intravitreal injections in patients with diabetes Semin. Ophthalmol. 29 2014 276 289
46. Y. Sook Kim, I. Soo Lee, and J. Sook Kim Protective effects of puerariae radix extract and its single compounds on methylglyoxal-induced apoptosis in human retinal pigment epithelial cells J. Ethnopharmacol. 152 2014 594 598
47. K.C. Sourris, and J.M. Forbes Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets Curr. Drug Targets 10 2009 42 50
48. A.W. Stitt, N. Lois, R.J. Medina, P. Adamson, and T.M. Curtis Advances in our understanding of diabetic retinopathy Clin. Sci. 125 2013 1 17
49. A.L. Wang, A.C. Yu, Q.H. He, X. Zhu, and M.O. Tso AGEs mediated expression and secretion of TNF alpha in rat retinal microglia Exp. Eye Res. 84 2007 905 913
50. C.M. Warboys, and P.A. Fraser Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature Microvas. Res. 80 2010 174 176
51. Qingwen Xu, T. Quam, and Anthony P. Adamis Sensitive blood-retinal barrier breakdown quantitation using Evans blue Investig. Ophthalmol. Vis. Sci. 42 2001 789 794
52. C. Yang, Z. Yuan, and J. Zhang Study on the effects of Simiao Yong an decoction on the vascular smooth muscle cell migration China J. Tradit. Chin. Med. Pharm. 28 2013 1480 1483
53. Y. Yang, and Q. Liu Clinical Trial of Combination of Six Ingredient Rehmannia Pill and Si-Miao-Yong-An Decoction on Diabetic Retinopathy ShenZhen J. Intergr. Tradit. Chin. West. Med. 18 2008 300 301
54. J.W. Yau, S.L. Rogers, R. Kawasaki, E.L. Lamoureux, J.W. Kowalski, T. Bek, S.J. Chen, J.M. Dekker, A. Fletcher, J. Grauslund, S. Haffner, R.F. Hamman, M.K. Ikram, T. Kayama, B.E. Klein, R. Klein, S. Krishnaiah, K. Mayurasakorn, J.P. O'Hare, T.J. Orchard, M. Porta, M. Rema, M.S. Roy, T. Sharma, J. Shaw, H. Taylor, J.M. Tielsch, R. Varma, J.J. Wang, N. Wang, S. West, L. Xu, M. Yasuda, X. Zhang, P. Mitchell, T.Y. Wong, and Meta-Analysis for Eye Disease Study Group. Global prevalence and major risk factors of diabetic retinopathy Diabetes care 35 2012 556 564
55. H. Yu, Q. Li, B. Zhang, and M. Jiang Anti-proliferative effects and mechanisms of serum containing Simiao Yongan Decoction on rabbit aortic smooth muscle cells during the insulin resistance state Chin. J. Exp. Tradit. Med. Formul. 19 2013 251 254
56. J. Zhang, Y. Xu, M. Li, L. Li, L. Peng, G. Zhang, C. Yang, and Y. Zhou Effect of Simiao Yong an decoction on oxidative stress and inflammation on atherosclerosis model rabbits J. Tradit. Chin. Med. 2010 72 74
57. L. Zhang, H.-y. Gao, M. Baba, Y. Okada, T. Okuyama, L.-j. Wu, and L.-b Zhan Extracts and compounds with anti-diabetic complications and anti-cancer activity from Castanea mollissina Blume (Chinese chestnut) BMC Complement. Altern. Med. 14 2014 422
58. Y. Zhang, J. Su, H. Li, W. Ruan, X. Liu, C. Ye, and J. Zou Combination of "Heying Prescription" and laser therapy for diabetic retinopathy Shanghai J. Tradit. Chin. Med. 46 2012 50 52